N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide
C28H31BrN4O2S — CID 142727824
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide
N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide (PubChem CID 142727824) has the molecular formula C28H31BrN4O2S and a molecular weight of 567.55 g/mol. Its IUPAC name is N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide.
Molecular Properties
| Compound Name | N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide |
|---|---|
| PubChem CID | 142727824 |
| Molecular Formula | C28H31BrN4O2S |
| Molecular Weight | 567.55 g/mol |
| Exact Mass | 566.14 |
| IUPAC Name | N-[1-[(3-bromo-4-piperidin-4-yloxyphenyl)methyl]piperidin-4-yl]-2-(6-cyano-1-benzothiophen-2-yl)acetamide |
| SMILES | N#Cc1ccc2cc(CC(=O)NC3CCN(Cc4ccc(OC5CCNCC5)c(Br)c4)CC3)sc2c1 |
| InChI | InChI=1S/C28H31BrN4O2S/c29-25-13-20(2-4-26(25)35-23-5-9-31-10-6-23)18-33-11-7-22(8-12-33)32-28(34)16-24-15-21-3-1-19(17-30)14-27(21)36-24/h1-4,13-15,22-23,31H,5-12,16,18H2,(H,32,34) |
| InChIKey | NQMMOTMONPWDSY-UHFFFAOYSA-N |
| XLogP | 4.99 |
| TPSA | 77.39 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 567.55 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142727824 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.